Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making
Year of publication: |
2008
|
---|---|
Authors: | Annemans, Lieven |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 26.2008, 5, p. 409-423
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Anastrozole | Aromatase-inhibitors | Cost-effectiveness | Early-breast-cancer | Exemestane | Letrozole | Tamoxifen |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness
Karnon, Jonathan, (2006)
-
Karnon, Jon, (2003)
-
Management of Advanced Breast Cancer: Defining the Role of Anastrozole
Keating, Gillian M., (2001)
- More ...
-
An integrative model of the management of hospital physician relationships
Trybou, Jeroen, (2010)
-
Trybou, Jeroen, (2016)
-
Kessels, Roselinde, (2014)
- More ...